Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Laws and Regulations

Type Signature Number Date Topic Document
Circular Minister of Public Health
 
9 9-3-2022 Related to providing specialized mental health medications in primary health care centers
 
Circular Number 9: Related to providing specialized mental health medications in primary health care centers
 
Decision Minister of Public Health 271/1 25/02/2019 Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision Minister of Public Health 270/1 25/02/2019 Related to the Quality of Care and Human Rights in the Field of Mental Health  Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health

Circular 

Director General

60

20/06/2018

Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system

Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system

Circular  Director General 112 27/11/2018 Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular  Director General 113 22/11/2018 Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational) Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision Minister of Public Health 1155 19-06-2018 Decision related to the National Mental Health Programme Decision number 1155: related to the National Mental Health Programme
Circular Director General 22 09-03-2018 Regulation of studies and research in the field of mental health and psychosocial support Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe   1320/1 02-2018 Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession. Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular Director General 48 12-06-2017 Regulation of research in the field of mental health Circular number 48: Related to the regulation of research in the field of mental health
Circular Director General 64 12-06-2017 Projects related to MHPSS and substance use in Lebanon Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular Director General 46 22-03-2016 Request to hospitals to not report on overdose Circular number 46: related to the request to hospitals to not report on overdose
Circular
 
Director General
 
66
 
20-6-2025
 
Regarding Specialized Mental Health Medications
 
Circular number 66: Concerning Specialized Mental Health Medications
 
    3
    ...
ATC Name B/G Ingredients Dosage Form Price
N05AX08 RISPERDAL B Risperidone - 1mg 1mg Tablet, film coated 323,866 L.L
N05AX08 RISPERDAL B Risperidone - 1mg 1mg Tablet, film coated 323,866 L.L
J06BB01 RHOPHYLAC 300 BioHuman Human anti-D (rh) immunoglobulin - 300mcg/2ml 300mcg/2ml Injectable solution 5,939,784 L.L
J06BB01 RHESONATIV BioHuman Human anti-D (rh) immunoglobulin - 625IU/ml 625IU/ml Injectable solution 12,281,758 L.L
J06BB05 RABISHIELD-100 (RABIES HUMAN MONOCLONAL ANTIBODY rDNA) BioHuman Rabies, Human IgG1 Monoclonal Antibody - 100IU/2.5ml 100IU/2.5ml 8,455,824 L.L
B02BD02 RECOFACT VIII BioTech Moroctocog alfa - 500IU 500IU Injectable powder for solution+diluent 12,049,005 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 500IU 500IU Injectable powder for solution+solvent 76,080,435 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 1000IU 1000IU Injectable powder for solution+solvent 149,006,584 L.L
B02BD04 REFIXIA BioTech Nonacog beta pegol (factor IX) - 2000IU 2000IU Injectable powder for solution+solvent 298,171,597 L.L
B02BD08 RECOFACT VII BioTech Eptacog alfa (activated) recombinant - 1.2mg 1.2mg Injectable powder for solution+diluent 47,533,131 L.L
J07BG01 RABIVAX-S (RABIES VACCINE INACTIVATED) BioTech Freeze dried inactivated purified rabies antigen (Pitman Moore PM3218 as virus strain) - Injectable freeze dried material 1,552,138 L.L
L03AB07 REBIF BioTech Interferon beta-1a - 44mcg/0.5ml 12MIU Injectable solution 82,479,505 L.L
L03AB07 RECIGEN 44 BioTech Interferon beta-1a - 44mcg/0.5ml 44mcg/0.5ml Injectable solution 15,147,973 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL FREEZE-DRIED) BioTech Rotavirus bovine-human , live attenuated - Suspension 2,822,069 L.L
J07BH01 ROTASIIL, ROTAVIRUS VACCINE, LIVE ATTENUATED (ORAL LIQUID) BioTech Rotavirus bovine-human , live attenuated - Liquid 2,822,069 L.L
A10AD06 RYZODEG BioTech Insulin degludec - 70%, Insulin aspart - 30% 100IU/ml Injectable solution 7,058,661 L.L
L03AB07 RECIGEN 44 BioTech Interferon beta-1a - 44mcg/0.5ml 44mcg/0.5ml Injectable solution L.L
C10AX13 REPATHA BioTech Evolocumab - 140mg/1ml Injectable solution 44,151,793 L.L
B03XA06 REBLOZYL BioTech Luspatarcept - 25mg 25mg Injectable powder for solution 125,960,784 L.L
B03XA06 REBLOZYL BioTech Luspatercept - 75mg 75mg Injectable powder for solution 377,881,318 L.L
L01FA01 RITUXIREL BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrated solution 11,708,063 L.L
L01FA01 RIXATHON BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 28,438,096 L.L
L01FA01 RUXIENCE BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrate for solution 13,157,756 L.L
L01FA01 RITUXIREL BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrated solution 45,258,360 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 66,951,899 L.L
L01FA01 RIXATHON BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 116,417,745 L.L
L01FA01 RUXIENCE BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrate for solution 59,148,151 L.L
L01FA01 RITUXIREL BioTech Rituximab - 100mg/10ml 100mg/10ml Injectable concentrated solution L.L
L01FA01 RITUXIREL BioTech Rituximab - 500mg/50ml 500mg/50ml Injectable concentrated solution L.L
L03AB07 REBIF BioTech Interferon beta-1a - 44mcg/0.5ml 12MIU Injectable solution L.L
    3
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025